FTRE Latest Press Releases

-- October 22, 2026 --

Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development Globe Newswire 4:05 PM

-- October 19, 2026 --

Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials Globe Newswire 4:05 PM

-- October 5, 2026 --

Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call Globe Newswire 6:30 AM

-- September 10, 2026 --

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:08 PM

Fortrea to Participate in September Investor Conferences Globe Newswire 8:58 AM

-- September 2, 2026 --

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials Globe Newswire 7:00 AM

-- July 29, 2026 --

Fortrea Reports Second Quarter 2026 Results Globe Newswire 6:30 AM

-- July 23, 2026 --

Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm Business Wire 7:00 AM

-- July 13, 2026 --

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call Globe Newswire 9:00 AM

-- June 26, 2026 --

Fortrea Names Jason Knoblauch as Chief Financial Officer Globe Newswire 7:00 AM

-- June 10, 2026 --

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:15 PM

-- June 2, 2026 --

Fortrea to Attend Jefferies Global Healthcare Conference Globe Newswire 6:12 PM

Market Data Delayed 15 Minutes